FORMATO, Marilena
 Distribuzione geografica
Continente #
NA - Nord America 3.970
EU - Europa 2.334
AS - Asia 1.663
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 18
SA - Sud America 9
AF - Africa 5
Totale 8.018
Nazione #
US - Stati Uniti d'America 3.945
CN - Cina 1.095
UA - Ucraina 1.093
SG - Singapore 473
DE - Germania 370
IT - Italia 290
FI - Finlandia 178
SE - Svezia 169
FR - Francia 78
GB - Regno Unito 76
KR - Corea 37
TR - Turchia 32
BE - Belgio 29
CA - Canada 23
AU - Australia 17
EU - Europa 17
BR - Brasile 8
DK - Danimarca 7
CZ - Repubblica Ceca 5
GR - Grecia 5
HR - Croazia 5
IN - India 5
JP - Giappone 5
IL - Israele 3
IR - Iran 3
LU - Lussemburgo 3
NL - Olanda 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
EG - Egitto 2
ES - Italia 2
IE - Irlanda 2
MA - Marocco 2
NO - Norvegia 2
PL - Polonia 2
RU - Federazione Russa 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 8.018
Città #
Chandler 1.028
Jacksonville 684
Singapore 368
Princeton 356
Nanjing 294
Dearborn 172
New York 166
Wilmington 147
Sassari 135
Nanchang 134
Ann Arbor 102
Boardman 98
Beijing 89
Shenyang 85
Hebei 71
Changsha 67
Tianjin 59
Jiaxing 46
Santa Clara 46
Woodbridge 45
Andover 39
Jinan 38
Seoul 37
Ashburn 36
Zhengzhou 35
Ningbo 34
Kunming 31
Mountain View 31
Brussels 29
Hangzhou 26
Izmir 26
Norwalk 24
San Francisco 22
Toronto 21
Guangzhou 16
Taizhou 15
Cagliari 14
Villiers-sur-marne 12
Helsinki 11
Changchun 10
Los Angeles 10
Lanzhou 9
Hanover 8
Dallas 7
Melbourne 7
Auburn Hills 6
Ficarazzi 6
Oristano 6
Shanghai 6
Augusta 5
Brno 5
London 5
Munich 5
San Mateo 5
Zagreb 5
Canberra 4
Leawood 4
Pátrai 4
Rome 4
Sydney 4
Tokyo 4
Verona 4
Ardabil 3
Edinburgh 3
Falls Church 3
Florence 3
Molfetta 3
Bangkok 2
Cairo 2
Cedar Knolls 2
Dublin 2
Fairfield 2
Frankfurt am Main 2
Fuzhou 2
Haikou 2
Hefei 2
Luxembourg 2
Monmouth Junction 2
Mumbai 2
Paris 2
Potenza 2
Qingdao 2
Romola 2
San Jose 2
Seattle 2
Senis 2
Serramanna 2
Shenzhen 2
São Paulo 2
Tappahannock 2
Tel Aviv 2
Torino 2
Turin 2
Villanovaforru 2
Warsaw 2
Wuxi 2
Acquaviva Delle Fonti 1
Adelaide 1
Agadir 1
Almere Stad 1
Totale 4.899
Nome #
Assessment of protein-incorporated arginine methylation in biological specimens by CZE UV-detection 93
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 86
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 77
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 75
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 75
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 74
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 73
A study of the switch of fetal hemoglobin in newborn erythrocytes fractionated by density gradient 71
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 70
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 70
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 68
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 66
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 66
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 66
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 65
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 64
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 63
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 62
Distribution of low - density lipoprotein-bound low molecular weight thiols: a new analytical approach 62
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 61
Biodiversità marina della Sardegna: prospettive di valorizzazione e sfruttamento sostenibile dei poriferi 61
Hemoglobin Hamilton [β11(A8)Val→Ile] in Sardinia 61
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 59
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 59
Morfogenesi cronica dei poriferi: la strutturazione della matrice extracellulare è modulata dai glicosaminoglicani? 58
Lipoprotein(a) and the arterial wall 57
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 57
Diagnosi neonatale delle emoglobinopatie mediante isoelettrofocusing delle Emoglobine 57
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 56
A reversed phase HPLC method for the simultaneous determination of all monosaccharides contained in galactosaminoglycan isomers from human aorta proteoglycans 56
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 56
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 56
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 56
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 55
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. IF 2000: 2.071 JCR: Q1 55
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 55
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 54
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 54
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 54
Differential proteomic analysis of human atherosclerotic plaque extracts 53
Identification and characterization of biomarkers in atherosclerosis and diabetes. 53
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 53
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 52
Urinary excretion of GAGs during hypocholesterolemic therapy 52
Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan. IF 2000: 7.368 JCR: Q1 50
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 50
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 50
Apolipoprotein Profiles in Atherosclerotic Disease 49
Role of the small proteoglycan bikunin in human reproduction 49
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 49
Apolipoprotein Profiles in Atherosclerotic Disease 49
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 49
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 49
Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques 48
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 48
Protein oxidation in unstable plaque extracts from human carotid segments 48
Apolipoprotein profiles in atherosclerotic disease 48
Buoyant density of Lp(a) subclasses in hypercholesterolemia 48
Cryopreservation of porcine aortic valve: open status of the aortic leaflets results in increased matrix glycosaminoglycan structural maintenance 47
Cellular adhesion of rat hepatocytes during the last phase of the phenotype differentiation 47
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 47
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 47
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 47
GAG and protein composition of GAG-protein complexes from normal human plasma 46
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 46
Determination of galactosaminoglycan disaccharides by high performance capillary electrophoresis: applications to analysis of human aorta proteoglycans 46
Investigation on the interactions between LDL and proteoglycans from human aortas 46
Estrogen receptors in the liver of intact and gonadectomized rats: determination by hydroxylapatite assay 46
Adhesion properties and proteoglycans produced by subsequent subcultures of rat fibroblasts with different contact inhibition 46
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 46
LDL interactions with different aorta proteoglycans 46
The role of GAGs in cell to cell adhesion of rat fibroblasts: a preliminary investigation 46
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 45
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 45
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 45
Atherosclerotic modifications of human proteoglycans 45
Factors affecting S-homocysteinylation of LDL apoprotein B 45
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 45
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 45
Preliminary investigations on LDL interactions with proteoglycans extracted from human aortic wall with different atherosclerotic lesions 45
Morfogenesi cronica dei poriferi: la struttura della matrice extracellulare è modulata dai glicosaminoglicani? 45
IDENTIFICATION, QUANTIFICATION AND STRUCTURAL CHARACTERIZATION OF GLYCOSAMINOGLYCANS FROM PORCINE AORTIC VALVE TISSUE 45
Serum Lp(a) levels in chronic haemodialysis patients 44
Valorizzazione e sfruttamento sostenibile dei poriferi: la spongicoltura nella fascia costiera 44
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 44
Generalized absence-like seizures induced by ketamine in the rat 44
Modifications of adhesion properties and proteoglycan structure in rat embryo fibroblast cultures with increasing passages 44
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 44
Glycosamynoglycan diversity in sponge extracellular matrix 43
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 43
CRYOPRESERVATION OF AORTIC VALVE:OPEN STATUS OF THE AORTIC LEAFLETS RESULTS IN INCREASED MATRIX GLYCOSAMINOGLYCAN MAINTENANCE 43
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 43
Modifications of low density lipoprotein induced by the interaction with heparin, chondroitin 6 sulphate and plasma high charge GAG-protein complexes 43
A study of the switch of fetal hemoglobin in newborn erytrocytes fractionated by density gradient. 43
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 43
Apolipoprotein profiles in atherosclerotic disease 43
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 43
Cryopreservation of porcine aortic valve on open status increased matrix glycosaminoglycan structural maintenance 43
The level of adenine nucleotides and pyridine coenzymes in newborn red blood cells simultaneously determined by HPLC. 43
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 43
Totale 5.309
Categoria #
all - tutte 42.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.076 0 0 0 0 180 152 283 19 190 48 202 2
2020/20211.249 176 7 206 7 174 38 176 4 200 197 43 21
2021/2022837 110 5 3 16 10 3 54 52 94 36 95 359
2022/20231.916 188 124 37 324 236 306 0 230 328 19 81 43
2023/2024594 93 41 15 16 133 102 6 32 9 12 76 59
2024/2025601 32 40 310 56 163 0 0 0 0 0 0 0
Totale 8.094